glp-1 news october 1 2025 KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and Use Understanding GLP-1s and their dynamic

In patients with diabetes mellitus not achieving targets on lifestyle measures, pharmacologic therapy should be considered

PBM pricing

Learn about Tresiba (insulin degludec), a once-daily, long-acting basal insulin for patients over 1 year of age with type 1 or type 2 diabetes

GLP-1 receptor agonists including semaglutide must be stopped before pregnancy due to animal studies showing potential fetal harm

Biocare is a nutritional beverage designed to work with GLP-1 medications, such as Wegovy, Ozempic, Mounjaro and Zepbound (semaglutide and tirzepatide)

Learn how this incretin hormone enhances insulin secretion and its therapeutic potential in diabetes and obesity management